Trial intelligence / Profile preview

Long-Term Follow-up of Chondrogen after Meniscectomy

NCT00702741Phase 2Completed

Sponsor
Mesoblast Ltd
Start
Jun 2008
Primary completion
Sep 2011
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of Chondrogen in meniscal tear, osteoarthritis (OA), sponsored by Mesoblast Ltd. Started Jun 2008; status: completed.

02

Drugs

Chondrogen
03

Conditions

meniscal tearosteoarthritis (OA)

Beyond the preview

Go deeper on NCT00702741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00702741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call